Cytek Biosciences, Inc.
USD4.38
+0.04 (+1.04%)
CEO
Wenbin Jiang
IPO Date
2021-07-23
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$4.32
Prev. Close
$4.34
Day Low
$4.26
Day High
$4.39
52W Low
$3.09
52W High
$6.18
Market Cap
$0.57B
Volume
0.47M
| -140.8 |
| 31 Dec 2023 | FY | 56.7% | -6.3% | -3.1% | -2.5% | 0.04 | 6.97 | -101.6 |
| 31 Dec 2022 | FY | 61.6% | 1.6% | 0.6% | 0.5% | 0.04 | 9.26 | 533.1 |
| 31 Dec 2021 | FY | 61.9% | 2.3% | 0.7% | 0.6% | 0.00 | 13.01 | 727.4 |
| 31 Dec 2020 | FY | 55.7% | 20.9% | -121.1% | 8.8% | -0.17 | 7.86 | 128.5 |
| 31 Dec 2019 | FY | 49.5% | -29.1% | 40.4% | -23.9% | 0.00 | 3.22 | -148.3 |
| -3.7 |
| 30 Sept 2025 | Q3 | 52.7% | -10.5% | -1.4% | -1.1% | 0.09 | 5.17 | -20.2 |
| 30 Jun 2025 | Q2 | 52.3% | -12.2% | -1.5% | -1.1% | 0.06 | 5.22 | -19.3 |
| 31 Mar 2025 | Q1 | 48.6% | -27.5% | -3.0% | -2.4% | 0.04 | 5.62 | -11.3 |
| 31 Dec 2024 | Q4 | 58.5% | 16.8% | 2.4% | 1.9% | 0.04 | 5.86 | 21.7 |
| 30 Sept 2024 | Q3 | 56.3% | 1.8% | 0.2% | 0.2% | 0.02 | 6.21 | 192.8 |
| 30 Jun 2024 | Q2 | 54.6% | -22.4% | -2.7% | -2.2% | 0.04 | 7.33 | -17.7 |
| 31 Mar 2024 | Q1 | 51.3% | -13.8% | -1.6% | -1.3% | 0.04 | 6.99 | -35.5 |
| 31 Dec 2023 | Q4 | 56.8% | 9.4% | 1.4% | 1.1% | 0.04 | 6.97 | 54.2 |